Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously possible. What will the likely future products of biotechnology be over the next 5â€"10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology? Preparing for Future Products of Biotechnology analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making. This report identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood.
This directory provides the reader with quick-access to information on more than 8000 companies, research centres and academic institutions involved in new and established technologies. This edition offers more than 600 all-new organization listings, including new listings in Europe.
The tremendous progress in biology over the last half century - from Watson and Crick's elucidation of the structure of DNA to today's astonishing, rapid progress in the field of synthetic biology - has positioned us for significant innovation in chemical production. New bio-based chemicals, improved public health through improved drugs and diagnostics, and biofuels that reduce our dependency on oil are all results of research and innovation in the biological sciences. In the past decade, we have witnessed major advances made possible by biotechnology in areas such as rapid, low-cost DNA sequencing, metabolic engineering, and high-throughput screening. The manufacturing of chemicals using biological synthesis and engineering could expand even faster. A proactive strategy - implemented through the development of a technical roadmap similar to those that enabled sustained growth in the semiconductor industry and our explorations of space - is needed if we are to realize the widespread benefits of accelerating the industrialization of biology. Industrialization of Biology presents such a roadmap to achieve key technical milestones for chemical manufacturing through biological routes. This report examines the technical, economic, and societal factors that limit the adoption of bioprocessing in the chemical industry today and which, if surmounted, would markedly accelerate the advanced manufacturing of chemicals via industrial biotechnology. Working at the interface of synthetic chemistry, metabolic engineering, molecular biology, and synthetic biology, Industrialization of Biology identifies key technical goals for next-generation chemical manufacturing, then identifies the gaps in knowledge, tools, techniques, and systems required to meet those goals, and targets and timelines for achieving them. This report also considers the skills necessary to accomplish the roadmap goals, and what training opportunities are required to produce the cadre of skilled scientists and engineers needed.
`Biotechnology' - the integrated use of biochemistry, microbiology, and chemical engineering for the technological application of the capabilities of microbes and cultured tissue cells - is quickly becoming pervasive and challenging, rapidly developing both new techniques and industries. The Economic and Social Dynamics of Biotechnology - a joint project between Statistics Canada, the Program of Research on Innovation, Management and Economy (PRIME) at the University of Ottawa, and CIRANO at the University of Quebec in Montreal - brings together economic, social, and statistical views on the dynamics of this set of emerging technologies. It examines the costs as well as the benefits - the challenges as well as the choices - of the rapidly expanding science-based world of biodiversity, biopharmaceuticals, and bioinformatics, and it provides suggestions for future work and research. This project fits into an ongoing research program at Statistics Canada to develop meaningful indicators for science, technology, and innovation in a technology-intensive economy. This book tells the story of the inner workings of innovation systems, technological systems, and competence blocs in the production, use, and diffusion of knowledge.
This book provides a comprehensive overview of socio-economic impact assessments for genetically modified organisms, including genetically modified crops. It features case studies involving Bt cotton and other selected crops with improved traits from six major institutions in India and combines field data with surveys on stakeholder perceptions. It also discusses global trends in the socio-economic assessment of GMOs and reviews the available literature on the economic assessment of GM crops and how various countries have implemented Article 26.1 of the Cartagena Protocol on Biosafety. Further, it explores cost–benefit analyses and sociological aspects of socio-economic assessments.Based on this, the book proposes a framework and offers guidelines for socio-economic assessment that can be adapted for various GM crops. Lastly, it examines the relevance of socio-economic impact assessment in light of new applications such as GM mosquitoes and gene drives. Given its scope, the book is of interest to all academics, policymakers, regulators, and general readers concerned about the broader impacts of GM crops and applications like gene drives.
The American chestnut, whitebark pine, and several species of ash in the eastern United States are just a few of the North American tree species that have been functionally lost or are in jeopardy of being lost due to outbreaks of pathogens and insect pests. New pressures in this century are putting even more trees at risk. Expanded human mobility and global trade are providing pathways for the introduction of nonnative pests for which native tree species may lack resistance. At the same time, climate change is extending the geographic range of both native and nonnative pest species. Biotechnology has the potential to help mitigate threats to North American forests from insects and pathogens through the introduction of pest-resistant traits to forest trees. However, challenges remain: the genetic mechanisms that underlie trees' resistance to pests are poorly understood; the complexity of tree genomes makes incorporating genetic changes a slow and difficult task; and there is a lack of information on the effects of releasing new genotypes into the environment. Forest Health and Biotechnology examines the potential use of biotechnology for mitigating threats to forest tree health and identifies the ecological, economic, and social implications of deploying biotechnology in forests. This report also develops a research agenda to address knowledge gaps about the application of the technology.
154 citations in English covering: biotechnology, bioengineering, transgenic topics, genetics, & ethics, mass media, society, consumers, public opinion, etc. Many citations have abstracts. Author & subject indexes.
